Marshall partnership aimed at anti-cancer drugs
HUNTINGTON, W.Va. – Marshall University is teaming up with an international biosciences company to develop potential anti-cancer drugs. The partnership is between the Marshall Institute for Interdisciplinary Research and the Joan C. Edwards School of Medicine and Shanghai’s HD Biosciences Co. Ltd. The partners will share the costs and risks of discovery and development of new drugs.
By the same token, they will jointly own any intellectual property and commercialization rights to products developed through the arrangement.
A representative with HD Biosciences says the Marshall medical school has developed viable drug candidates over the years. He said the collaboration will speed what is typically a long process and spread the costs.